Published in Brain on May 04, 2005
CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell (2010) 2.40
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain (2007) 1.94
An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J Neurosci Methods (2009) 1.48
Cause and prevention of demyelination in a model multiple sclerosis lesion. Ann Neurol (2016) 1.41
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation (2010) 1.41
Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol (2010) 1.37
Neuropathic pain and cytokines: current perspectives. J Pain Res (2013) 1.26
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One (2013) 1.10
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage (2013) 1.01
Effects of aging and calorie restriction on white matter in rhesus macaques. Neurobiol Aging (2010) 0.98
Modeling multiple sclerosis in laboratory animals. Semin Immunopathol (2009) 0.94
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol (2014) 0.93
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures. J Neuroinflammation (2011) 0.86
Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. J Cell Mol Med (2009) 0.85
Identification of an emerin-beta-catenin complex in the heart important for intercalated disc architecture and beta-catenin localisation. Cell Mol Life Sci (2009) 0.84
NG2 cells response to axonal alteration in the spinal cord white matter in mice with genetic disruption of neurofilament light subunit expression. Mol Neurodegener (2008) 0.83
Upregulation of CBLL1 in rat brain cortex after lipopolysaccharide treated. J Mol Histol (2012) 0.83
Elevated beta1,4-galactosyltransferase-I induced by the intraspinal injection of lipopolysaccharide. Glycoconj J (2008) 0.82
Multiple sclerosis: experimental models and reality. Acta Neuropathol (2016) 0.82
Loss of myelin-associated glycoprotein in kearns-sayre syndrome. Arch Neurol (2012) 0.81
Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators Inflamm (2013) 0.81
In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes. J Neuroimmunol (2010) 0.80
Astrocyte Activation via Stat3 Signaling Determines the Balance of Oligodendrocyte versus Schwann Cell Remyelination. Am J Pathol (2015) 0.80
The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol (2010) 0.79
Glial restricted precursors maintain their permissive properties after long-term expansion but not following exposure to pro-inflammatory factors. Brain Res (2015) 0.78
Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury. Exp Neurol (2015) 0.78
Involvement of CtBP2 in LPS-induced microglial activation. J Mol Histol (2012) 0.77
Involvement of SRC-suppressed C kinase substrate in neuronal death caused by the lipopolysaccharide-induced reactive astrogliosis. Inflammation (2010) 0.76
Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline. Cell Mol Neurobiol (2015) 0.76
Effect of age and calorie restriction on corpus callosal integrity in rhesus macaques: a fiber tractography study. Neurosci Lett (2014) 0.76
Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis. Sci Rep (2016) 0.76
E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord. Glia (2017) 0.76
Schwann Cell-Mediated Preservation of Vision in Retinal Degenerative Diseases via the Reduction of Oxidative Stress: A Possible Mechanism. Med Hypothesis Discov Innov Ophthalmol (2016) 0.75
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis (2007) 2.19
A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer (2007) 2.15
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol (2010) 2.03
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain (2007) 1.94
Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol (2003) 1.88
A novel paralogous gene family involved in phase-variable flagella-mediated motility in Campylobacter jejuni. Microbiology (2002) 1.84
Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab (2010) 1.71
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol (2013) 1.70
Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol (2004) 1.68
Economics of influenza vaccine administration timing for children. Am J Manag Care (2010) 1.65
Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients. Infect Control Hosp Epidemiol (2008) 1.61
Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain (2004) 1.60
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Brain (2013) 1.53
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. Pharmacoeconomics (2010) 1.46
A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children. Pediatr Blood Cancer (2010) 1.44
Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. Am J Kidney Dis (2012) 1.44
Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J (2008) 1.42
The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure. J Ment Health Policy Econ (2012) 1.42
Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol (2012) 1.41
InterStim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary Incontinence: A Decision Analysis Comparing Outcomes Including Efficacy and Complications. Female Pelvic Med Reconstr Surg (2011) 1.38
Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol (2010) 1.37
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab (2012) 1.24
The timing of influenza vaccination for older adults (65 years and older). Vaccine (2009) 1.21
Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine (2010) 1.19
Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults. J Gen Intern Med (2014) 1.17
To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling. PLoS One (2010) 1.13
Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst (2006) 1.11
Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol (2010) 1.09
Forecasting the economic value of an Enterovirus 71 (EV71) vaccine. Vaccine (2010) 1.07
High resolution (13)C MRI with hyperpolarized urea: in vivo T(2) mapping and (15)N labeling effects. IEEE Trans Med Imaging (2013) 1.05
Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol (2006) 0.98
Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. Chest (2005) 0.96
Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. J Magn Reson Imaging (2011) 0.95
Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier. Brain (2006) 0.95
Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis (2006) 0.94
A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population. Vaccine (2009) 0.92
The potential economic value of a hookworm vaccine. Vaccine (2010) 0.91
The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a Markov model. J Urol (2011) 0.91
Economic model for emergency use authorization of intravenous peramivir. Am J Manag Care (2011) 0.89
Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer. Gynecol Oncol (2011) 0.89
Cost-effectiveness of implementing the chronic care model for diabetes care in a military population. J Diabetes Sci Technol (2011) 0.89
Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective. Thromb Res (2013) 0.88
Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine (2011) 0.88
Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J Neurol Sci (2005) 0.88
Retropubic and transobturator midurethral slings: a decision analysis to compare outcomes including efficacy and complications. Int Urogynecol J (2010) 0.87
Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis. Obstet Gynecol (2007) 0.86
Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.86
Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol (2009) 0.86
Screening cardiac surgery patients for MRSA: an economic computer model. Am J Manag Care (2010) 0.83
MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro Oncol (2011) 0.83
The potential economic value of a Staphylococcus aureus vaccine for neonates. Vaccine (2010) 0.82
Reliability of laparoscopic compared with hysteroscopic sterilization at 1 year: a decision analysis. Obstet Gynecol (2011) 0.82
Cost-effectiveness of endoscopic sphenopalatine artery ligation versus nasal packing as first-line treatment for posterior epistaxis. Int Forum Allergy Rhinol (2013) 0.81
A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy. Laryngoscope (2012) 0.81
Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model. Alcohol Clin Exp Res (2009) 0.81
Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome. J Neuroimmunol (2007) 0.81
Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients. J Vasc Surg (2010) 0.81
Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy. J Card Fail (2010) 0.81
The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach. Laryngoscope (2011) 0.81
FDA warning and removal of rosiglitazone from VA national formulary. Am J Manag Care (2013) 0.81
Managing mesh exposure following vaginal prolapse repair: a decision analysis comparing conservative versus surgical treatment. Int Urogynecol J (2012) 0.81
Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis. Value Health (2013) 0.80
Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation. PLoS One (2012) 0.79
Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation: a cost-effectiveness analysis from a U.S. perspective. Thromb Haemost (2012) 0.79
Cost-effectiveness of pneumococcal and influenza vaccination standing order programs. Am J Manag Care (2013) 0.79
An innovative triple immunogold labeling method to investigate the hemopoietic stem cell niche in situ. Microsc Microanal (2009) 0.78
Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application. CNS Drugs (2010) 0.78
Oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Am J Med (2005) 0.78
Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective. J Pediatr (2009) 0.77
Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States. BMC Public Health (2014) 0.77
Microtomographic analysis of lower urinary tract obstruction. Pediatr Dev Pathol (2013) 0.76
Anticoagulation duration in heterozygous factor V Leiden: a decision analysis. Thromb Res (2013) 0.76
Cognitive-affective resilience indicia as predictors of burnout and job-related outcome. Int J Emerg Ment Health (2008) 0.76
Axonal morphological changes following impulse activity in mouse peripheral nerve in vivo: the return pathway for sodium ions. J Physiol (2015) 0.76
Cost-identification analysis of total laryngectomy: an itemized approach to hospital costs. Otolaryngol Head Neck Surg (2011) 0.75
Herpes zoster vaccine and older adults. JAMA (2011) 0.75
Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study. Am J Epidemiol (2017) 0.75
Brain-derived neurotrophic factor in experimental autoimmune neuritis. J Neuroimmunol (2002) 0.75
Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism. Thromb Haemost (2005) 0.75
Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo. Neuropharmacology (2012) 0.75
Cost-effectiveness of transoral robotic surgery in the unknown primary: corrigendum and response to comments. Otolaryngol Head Neck Surg (2014) 0.75
Probability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization. Contraception (2015) 0.75
The role of CD8(+) T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein. Mult Scler (2011) 0.75
Optimal approach to improving trauma triage decisions: a cost-effectiveness analysis. Am J Manag Care (2012) 0.75
A defining aspect of human resilience in the workplace: a structural modeling approach. Disaster Med Public Health Prep (2011) 0.75
Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients. Appl Health Econ Health Policy (2013) 0.75
Lamotrigine monotherapy does not provide protection against the loss of optic nerve axons in a rat model of ocular hypertension. Exp Eye Res (2012) 0.75
Cost-effectiveness of a statewide falls prevention program in Pennsylvania: Healthy Steps for Older Adults. Am J Manag Care (2016) 0.75
A multispectral microscope for in vivo oximetry of rat dorsal spinal cord vasculature. Physiol Meas (2016) 0.75
Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers. Oncol Res (2015) 0.75
Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia. J Pediatr Hematol Oncol (2014) 0.75
Incremental cost-effectiveness of various monthly doses of vardenafil. Value Health (2011) 0.75
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion (2007) 0.75
Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix. Int J Cancer (2011) 0.75
Promoting Organ Donor Registries Through Public Education: What Is the Cost of Securing Organ Donors? Transplantation (2016) 0.75
Direct paramedic transport of acute myocardial infarction patients to percutaneous coronary intervention centers: a decision analysis. Ann Emerg Med (2008) 0.75
Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia. J Pediatr (2010) 0.75